Authoritative Health Authorities & Medical Knowledge Base
Bypassing media sensationalism and PR marketing. Direct access to official regulatory bodies, international trial registries, and peer-reviewed journals.
Why We Built This Open Directory
Patients and families facing critical diagnoses are vulnerable to hype and deceptive marketing. This directory empowers readers to verify primary clinical trial files and peer-reviewed studies directly.
Global Health Authorities & Clinical Registries
Featuring Republic of China MOHW/TFDA, U.S. FDA, European EMA, Japan PMDA, WHO, and ClinicalTrials.gov. Access approved drug labels, active recruiting trials, and compassionate use (EAP) pathways.
Explore Health Authorities List →High-Impact Medical Journals & Databases
Covering the Big Four clinical journals (NEJM, Lancet, JAMA, BMJ), CNS flagship journals, PubMed/PMC archive, Cochrane Library systematic reviews, and preprint platforms with Open Access reading tips.
Browse Top Medical Journals →4-Step Guide to Debunking Sensationalized Medical Hype
Distinguish Preclinical Models from Human Trials
When headlines claim a "cancer cure," verify whether it was tested in petri dishes or mice. Over 90% of compounds showing promise in mice fail in human clinical trials due to lack of efficacy or unacceptable toxicity.
Demand the NCT Clinical Trial Identifier
Legitimate international human trials are registered on ClinicalTrials.gov or WHO ICTRP with a unique NCT identifier. If a claim lacks any trial registration number, treat it with extreme skepticism.
Look for Blinded Controls and Hard Endpoints
Check whether a study includes a control cohort. Anecdotal patient testimonials frequently reflect placebo effects. Focus on overall survival (OS) rather than surrogate biochemical markers cherry-picked by sponsors.
Verify Rigorous Peer Review in Top Journals
Genuine scientific breakthroughs undergo rigorous peer review in reputable journals like NEJM, The Lancet, Nature, or Cell. Be wary of announcements made exclusively via press conferences or pay-to-publish outlets.
